UK markets close in 4 hours 15 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.79+1.78 (+13.68%)
At close: 04:00PM EDT
14.48 -0.31 (-2.10%)
Pre-market: 07:12AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3344
Avg. Estimate0.06-0.85-0.19-1.13
Low estimate-1.17-0.96-1.59-2.18
High estimate2.16-0.681.21-0.11
Year ago EPS0.58-1.26-5.41-0.19
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3344
Avg. Estimate193.87M56.93M902.26M545.95M
Low estimateN/A41.8M775M50M
High estimate531.6M75M1.03B882.8M
Year ago salesN/A186.99M983.71M902.26M
Sales growth (year/est)N/A-69.60%-8.30%-39.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.39-1.83-0.45-1.06
Actual EPS0.58-1.26-1.44-1.05
Difference1.970.57-0.990.01
Surprise %141.70%31.10%-220.00%0.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.06-0.85-0.19-1.13
7 days ago-0.85-0.78-0.48-0.35
30 days ago-1-0.86-0.73-0.05
60 days ago-1.03-0.91-0.80.12
90 days ago-1.6-1.14-0.39-0.04
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days112N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVAXIndustrySector(s)S&P 500
Current qtr.-89.70%N/AN/AN/A
Next qtr.32.50%N/AN/AN/A
Current year96.50%N/AN/AN/A
Next year-494.70%N/AN/AN/A
Next 5 years (per annum)37.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A